Cancel
Kamran Alam
Executive Vice President, Finance & Chief Financial Officer
@
Notch Therapeutics
v7ry7@i8sjbjr.z35
Sign up to see email
Known information
- Served as Interim Chief Financial Officer of Neoleukin Therapeutics, Inc. following Neoleukin's merger in 2019 with Aquinox Pharmaceuticals, Inc.
- Provided finance leadership for Aquinox Pharmaceuticals' IPO on the NASDAQ stock exchange in 2014
- Held senior roles in business development for a number of biotechnology and pharmaceutical companies
- Is a Chartered Professional Accountant
- Holds a B.Sc. in Cell Biology and Genetics from the University of British Columbia
- Holds an M.B.A. in International Business and Strategy from the University of Victoria
About Notch Therapeutics
Notch Therapeutics is a biotechnology company that develops cellular immunotherapies for cancer treatment, utilizing a proprietary platform to engineer pluripotent stem cells into therapeutic cells.
Report inaccurate information
